• Title/Summary/Keyword: Medical school faculty

Search Result 725, Processing Time 0.026 seconds

Faculty Development for Medical Faculty: Importance and Strategies (의과대학 교수의 경력개발: 필요성과 실행전략)

  • Do-Hwan Kim
    • Korean Medical Education Review
    • /
    • v.25 no.1
    • /
    • pp.3-16
    • /
    • 2023
  • Unlike in the past, standards for the quantity and quality of work expected from medical school faculty are continuously rising, causing changes and stress in various areas. This highlights the need for career development among medical school faculty for professional, personal, organizational, and societal reasons. The role of medical school faculty has become more diverse, leading to an increase in the types and levels of competencies required. Medical schools must support their faculty members with diverse identities in fully utilizing their capabilities to achieve the institution's mission. Furthermore, societal changes suggest that career development for medical school faculty will become even more crucial in the future. To achieve this, both individuals and organizations must make efforts and play appropriate roles. For this purpose, medical schools use a combination of promotion and tenure evaluations and faculty development programs, while individual faculty members follow a career path within the medical school environment. Medical school faculty must be able to meet the evolving demands at each stage of their careers. It is important for professors, who engage in career development, to have a clear sense of their identity and values, and to prioritize their career goals. Medical schools should also ensure that the implicit messages they convey align with the organization's explicit values. Finally, proactively preparing for future changes in society and generations is essential from a long-term perspective.

Priority Analysis of the Determining Factors of Faculty Startups in Medical Schools (의과대학 교원 창업 결정요인 우선순위 분석)

  • Sung Jin Chung;Dae Geun Kim
    • Korea Journal of Hospital Management
    • /
    • v.29 no.3
    • /
    • pp.11-25
    • /
    • 2024
  • Purpose: This study investigates the factors influencing medical school faculty's entrepreneurial decisions and prioritizes these factors. Methodology: The study examines the determinants of entrepreneurial decisions among medical school faculty by reviewing prior studies. These determinants were categorized into four perspectives: resource-based, industrial organization, entrepreneur characteristics, and other. Using the Analytic Hierarchy Process(AHP), the study analyzed the relative priorities of 27 specific indicators. Surveys were conducted with medical school faculty with startup experience, professors with relevant expertise, and organizational leaders involved in entrepreneurship. A total of 33 responses were validated for consistency, and an empirical analysis identified the priority of factors influencing medical school faculty startups. Findings: The findings reveal that 'entrepreneur characteristics' and 'institutional and organizational support' are the highest priority factors for medical school faculty. Key resource-based factors include the 'leave of absence' or 'concurrent employment policy,' availability of 'professional human resources,' and 'organizational support' specializing in startups. An integrated analysis shows that while intellectual resources such as research publications, patents, and physical space are necessary, the highest priority is given to leave policies, professional human resources, and organizational support. Practical Implication: Medical school faculty are recognized as key innovation agents in the bio-health industry. The results provide crucial insights for policymakers and stakeholders at governmental, institutional, and organizational levels. Strengthening self-competence, increasing entrepreneurship opportunities, and establishing professional human resources and organizational support within medical universities or hospitals are critical for facilitating medical school faculty startups.

  • PDF

Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells

  • Nasiri, Marzieh;Zarghami, Nosratollah;Koshki, Kazem Nejati;Mollazadeh, Mahdieh;Moghaddam, Mohammad Pourhassan;Yamchi, Mohammad Rahmati;Esfahlan, Rana Jahanban;Barkhordari, Amin;Alibakhshi, Abbas
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.6
    • /
    • pp.3449-3453
    • /
    • 2013
  • Background: Telomerase has been considered as an attractive molecular target for breast cancer therapy. The main objective of this work is to assess the inhibitory effects of silibinin and curcumin, two herbal substances, on telomerase gene expression in breast cancer cells. Materials and Methods: For determination of cell viability tetrazolium-based assays were conducted after 24, 48, and 72 h exposure times and expression of human telomerase reverse transcriptase gene was measured with real-time PCR. Results: Each compound exerted cytotoxic effects on T47D cells and inhibited telomerase gene expression, both in a time-and dose-dependent manner. The mixture of curcumin and silibinin showed relatively more inhibitory effect on growth of T47D cells and hTERT gene expression as compared with either agent alone. Conclusions: These findings suggest that cell viability along with hTERT gene expression in breast cancer cells could be reduced by curcumin and silibinin.

Clinicopathological Features and Localization of Gastric Cancers and their Effects on Survival in Turkey

  • Selcukbiricik, Fatih;Tural, Deniz;Bilici, Ahmet;Uzel, Esengul Kocak;Ozguroglu, Mustafa;Demirelli, Fuat;Buyukunal, Evin;Serdengecti, Suheyla
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.14 no.1
    • /
    • pp.553-556
    • /
    • 2013
  • Background: This study was designed to examine changing trends in localization of gastric cancer in Turkey in recent years. Materials and Methods: A total of 796 adult patients with newly diagnosed, histologically proven adenocarcinomas, treated and followed up at our oncology center between 2000-2011, were examined retrospectively. In all cases tumor localization were identified and recorded with clinicopathological features. Results: The median age was 58 with a range between 22-90 for the 552 men and 244 women. Median follow up was 12 months (1-276) and median overall survival was also 12 months (11.5-12.4). There was a trend for a change in tumor localization from distal to proximal. Survival of patients was low with advanced T and N stage tumours. Positive surgical margins, lymphovascular invasion, perineural invasion, cardioesophageal localization were predisposition factors for metastatic disease in gastric cancer. There was no relation between age or sex and histopathological type of gastric cancer. Conclusions: There is a trend in our country for a change in gastric tumour localization from distal to proximal, with clear significance for treatment choices.

Development of New Job Classification Method in Job Elements Analysis for the Purpose of Human Cost Calculation in Hospitals

  • Numasaki, Hodaka;Harauchi, Hajime;Okura, Yasuhiko;Ishii, Atsue;Kasahara, Satoko;Monden, Morito;Sakon, Masato;Bando, Masako;Ohno, Yuko;Inamura, Kiyonari
    • Proceedings of the Korean Society of Medical Physics Conference
    • /
    • 2002.09a
    • /
    • pp.492-494
    • /
    • 2002
  • We established the job classification method that a classification standard is clear, and can subdivide job by using the raw data of time-and-motion study performed to analyze the medical staffs job elements. The final target of this study is to optimize job allocation and calculate human cost of medical staffs in hospitals.

  • PDF

Multi-Institutional Database System for The Aid of Improvement in Radiotherapy Results

  • Ishibashi, Masatoshi;Harauchi, Hajime;Kou, Hiroko;Kumazaki, Yu;Shimizu, Keiji;Harano, Masako;Numasaki, Hodaka;Yoshioka, Munenori;Inamura, Kiyonari
    • Proceedings of the Korean Society of Medical Physics Conference
    • /
    • 2002.09a
    • /
    • pp.126-128
    • /
    • 2002
  • A learning system was built into an on-line, multi-institutional radiotherapy database, where the treatment history records and the results in each institution were integrated, each radiotherapy planning was supported, and it led to the improvement in treatment results.

  • PDF

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

  • Cabuk, Devrim;Basaran, Gul;Teomete, Mehmet;Dane, Faysal;Korkmaz, Taner;Seber, Selcuk;Telli, Ferhat;Yumuk, Perran Fulden;Turhal, Serdar
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.15 no.1
    • /
    • pp.117-122
    • /
    • 2014
  • Background: Breast cancer is the most common malignancy and the second leading cause of cancer-related death among women in the developed countries. Despite advances in screening, improved local therapies and adjuvant systemic treatments, median survival of metastatic breast cancer patients (MBC) is in the range of 2-3 years at most. We aimed to investigate whether the prognostic factors and therapeutic responses of our Turkish patients are similar to those in the literature. Materials and Methods: We reviewed the medical records of MBC patients who had been treated in our institution between 1999-2009 and analyzed their clinicopathological features and survival outcomes retrospectively Results: A hundred and sixty patients were included. Median age was 47 (23-82), median follow up was 24 (2-186) months. At the time of diagnosis 59% of patients were under the age of 50 and 46% were postmenopausal. The majority (37%) had multiple sites of metastases. Forty percent received endocrine therapy and 40% chemotherapy as first line metastatic treatment. Thirty (20%) patients were treated with molecular targeting agents like trastuzumab, lapatinib and sunitinib, frequently combined with a chemotherapy agent. Five-year overall survival (OS) was 32% and median OS was 38 months for the whole group. Five year progression free survival (PFS) was 10% and median PFS was 10 months. Menopausal status, hormone receptor expression and disease free status had a significant impact on overall survival in the multivariate analysis (p 0.018, p 0.018 and p:0.003, respectively). Conclusions: All our patients were treated with the modern oncologic therapies recommended by the international guidelines. From our data, MBC patients live up to 3-4 years, indicating that further improvement beyond that requires development of new treatment modalities. The survival outcomes of our patients were consistent with the data reported in the literature.